Seoul, South Korea

Joo Hwan Cha

This inventor holds 8 USPTO granted patents. Top assignees: Korea Institute of Science and Technology, Korea Research Institute of Chemical Technology. Active years: 2005-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joo Hwan Cha. Retrieved from https://idiyas.com/inventor/joo-hwan-cha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Joo Hwan Cha: Innovating Treatments for CNS Disorders

Introduction

Joo Hwan Cha, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of pharmaceutical chemistry. With a total of eight patents to his name, his innovative work focuses on developing new therapeutic agents aimed at treating various central nervous system (CNS) disorders. His expertise lies in creating novel compounds that can effectively address complex mental health issues.

Latest Patents

Among Joo Hwan Cha’s latest contributions are his patents for piperazinyl-propyl-pyrazole derivatives, which act as dopamine D4 receptor antagonists. These compounds demonstrate a superior selective affinity for the dopamine D4 receptor and can effectively inhibit psychotic behavior induced by apomorphine, showcasing low adverse effects in tests. The applications of these derivatives extend to treating a wide array of CNS disorders, such as schizophrenia, attention deficit hyperactivity disorder (ADHD), depression, and various anxiety disorders, among others.

Career Highlights

Throughout his illustrious career, Joo Hwan Cha has held positions at prominent research institutions, including the Korea Institute of Science and Technology and the Korea Research Institute of Chemical Technology. His experience in these institutions has enriched his research and innovation capabilities, enabling him to develop groundbreaking compounds that can significantly improve patient outcomes in the field of mental health.

Collaborations

During his career, Joo Hwan Cha has collaborated with fellow researchers, including Yong Seo Cho and Ae Nim Pae. These partnerships have led to fruitful exchanges of ideas and a collaborative effort in advancing research in pharmaceutical developments, enhancing the overall impact of their work in the medical community.

Conclusion

Joo Hwan Cha stands out as a pioneering inventor dedicated to addressing the complexities of CNS disorders through innovative pharmaceutical solutions. His contributions, marked by multiple patents and collaborative work with esteemed colleagues, continue to pave the way for new treatments that hold the potential to change lives. As he progresses in his research, the implications of his work could lead to significant advancements in mental health care and therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…